YAP/TAZ: Molecular pathway and disease therapy
Authors:
Open Access
Abstract
The Yes‐associated protein and its transcriptional coactivator with PDZ‐binding motif (YAP/TAZ) are two homologous transcriptional coactivators that lie at the center of a key regulatory network of Hippo, Wnt, GPCR, estrogen, mechanical, and metabolism signaling. YAP/TAZ influences the expressions of downstream genes and proteins as well as enzyme activity in metabolic cycles, cell proliferation, inflammatory factor expression, and the transdifferentiation of fibroblasts into myofibroblasts. YAP/TAZ can also be regulated through epigenetic regulation and posttranslational modifications. Consequently, the regulatory function of these mechanisms implicates YAP/TAZ in the pathogenesis of metabolism‐related diseases, atherosclerosis, fibrosis, and the delicate equilibrium between cancer progression and organ regeneration. As such, there arises a pressing need for thorough investigation of YAP/TAZ in clinical settings. In this paper, we aim to elucidate the signaling pathways that regulate YAP/TAZ and explore the mechanisms of YAP/TAZ‐induce diseases and their potential therapeutic interventions. Furthermore, we summarize the current clinical studies investigating treatments targeting YAP/TAZ. We also address the limitations of existing research on YAP/TAZ and propose future directions for research. In conclusion, this review aims to provide fresh insights into the signaling mediated by YAP/TAZ and identify potential therapeutic targets to present innovative solutions to overcome the challenges associated with YAP/TAZ.Keywords
Funding Information
- National Natural Science Foundation of China (32171308, 81600896)
This publication has 398 references indexed in Scilit:
- Tumor‐propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasisThe EMBO Journal, 2014
- TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsOncogene, 2014
- SOX2 Regulates YAP1 to Maintain Stemness and Determine Cell Fate in the Osteo-Adipo LineageCell Reports, 2013
- Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1Proceedings of the National Academy of Sciences, 2013
- Role of TAZ as Mediator of Wnt SignalingCell, 2012
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainProceedings of the National Academy of Sciences, 2012
- A Novel Acetylation Cycle of Transcription Co-activator Yes-associated Protein That Is Downstream of Hippo Pathway Is Triggered in Response to SN2 Alkylating AgentsJournal of Biological Chemistry, 2012
- YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophyProceedings of the National Academy of Sciences, 2012
- Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart SizeScience, 2011
- Structural Features and Ligand Binding Properties of Tandem WW Domains from YAP and TAZ, Nuclear Effectors of the Hippo PathwayBiochemistry, 2011